We're thrilled to share that our CEO Jean-Philippe Combal will join a panel of key industry leaders at the 10th Annual LSX World Congress to provide insight on best practices, strategies and real-life experiences that drive innovation in cell and gene therapy (#CGT).
Paris, France, April 23, 2024 - Vivet Therapeutics (“Vivet”), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders, is pleased to announce that its management team will be participating and presenting at the following scientific and business conferences in April, May and June in 2024.
Vivet Therapeutics Co-founder and Chief Scientific Officer, Gloria Gonzalez-Aseguinolaza will be participating in a round table discussion on 'Therapeutic Advances' on the 'Current Situation of Rare Diseases in Spain'.
Vivet Therapeutics is heading to Rome for the 2024 Cell & Gene Meeting on the Med from 9 - 11 April.
Come and listen to our CEO, @Jean-Philippe Combal on 9 April at 10am CEST, where he will deliver a presentation on hashtagVivet's diversified pipeline of hashtagrAAV based hashtaggenetherapies for rare inherited liver metabolic disorders including hashtagWilsonsDisease and hashtagCTX.
Come and listen to our CEO, @Jean-Philippe Combal on 9 April at 10am CEST, where he will deliver a presentation on hashtagVivet's diversified pipeline of hashtagrAAV based hashtaggenetherapies for rare inherited liver metabolic disorders including hashtagWilsonsDisease and hashtagCTX.
Vivet Therapeutics Chief Executive Officer, Jean-Philippe Combal will be attending the 7th Annual Gene Therapy for Rare Disorders Summit, taking place from 26-29 March in Boston, MA!
Jean-Philippe Combal - CEO and Gloria Gonzalez - CSO, are going to San Francisco for #JPM24! Let's make the most of this opportunity. Please send a message if you would like to schedule a meetup: info@vivet-therapeutics.com. #Wilsonsdisease #genetherapy #innovation #letsconnect
The Vivet Therapeutics team had the honor of sponsoring and attending the Spanish Wilson’s Disease Association meeting in Valencia, Spain (learn more: https://lnkd.in/eUMB-AUw ) over the last weekend.
Vivet Therapeutics is pleased to join AASLD - The Liver Meeting in Boston, MA this year.
Meet with Vivet Therapeutics for an update on the GATEWAY gene therapy clinical trial for Wilson disease – booth B908
Meet with Vivet Therapeutics for an update on the GATEWAY gene therapy clinical trial for Wilson disease – booth B908
Excited to kick off ESGCT's 30th Annual Congress in Brussels today!
Join Vivet's New Programs and Innovation Lead @Nicholas Weber, Ph.D. as he presents on the topic "Gene Therapy for Metabolic Diseases" on 25 October at 2:30 pm.
Join Vivet's New Programs and Innovation Lead @Nicholas Weber, Ph.D. as he presents on the topic "Gene Therapy for Metabolic Diseases" on 25 October at 2:30 pm.